Compounding pharmacies; use of bulk drug substances, recordkeeping.

Summary

The bill adds rules for when pharmacists can use bulk drug substances to make compounded medicines and bans use of substances that have been withdrawn for safety or are still under an unapproved investigational new drug application. It also forbids creating compounded products that are essentially identical to commercially available drugs. Pharmacies must provide the Board of Pharmacy with records of all compounded products within 48 hours of request, and the Board may share investigation information with the National Association of Boards of Pharmacy.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share